{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:20:11Z","timestamp":1782958811727,"version":"3.54.5"},"reference-count":43,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Victor Babes, University of Medicine and Pharmacy, Timisoara"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Systemic inflammatory markers from an ordinary complete blood count (CBC) may foreshadow where non-small-cell lung cancer (NSCLC) will first spread, but organ-specific signatures remain poorly defined. Materials and Methods: We retrospectively reviewed 302 adults (mean age 60.7 \u00b1 13.4 years; 80.8% men) with stage IV NSCLC managed at OncoHelp Medical Center, Timi\u0219oara, between January 2022 and December 2024. Eligibility demanded a single radiologically confirmed distant site at diagnosis and pre-treatment CBC. Neutrophil-to-lymphocyte (NLR), platelet-to-lymphocyte (PLR), and lymphocyte-to-monocyte (LMR) ratios were compared across pleural (n = 52), bone (n = 86), liver (n = 66), and brain (n = 98) metastases using Kruskal\u2013Wallis tests with Bonferroni adjustment; z-standardized logistic models identified independent predictors. Results: Metastases clustered most often in brain (32.5%), followed by bone (28.5%), liver (21.9%), and pleura (17.2%). Median PLR rose selectively in pleural disease (274 vs. 217\u2013253 in other sites; p = 0.006). LMR fell to 2.0 in bone but climbed to 2.8 in brain lesions (p = 0.032 and 0.008, respectively). NLR was globally elevated (6.7\u20137.6), yet differed significantly only for bone and liver deposits. Logistic modeling showed that each standard-deviation rise in absolute neutrophil count quadrupled the odds of hepatic involvement (Odd Ratio (OR) 4.26; 99% Confidence inerval (CI) 2.20\u20136.25), monocytosis nearly doubled bone risk (OR 1.83; 1.01\u20133.33), while higher erythrocytes, eosinophils, and lymphocytes independently protected against pleural seeding (all p &lt; 0.01). Age-stratified analysis revealed that osseous and cerebral metastases predominated in patients \u2264 50 years, whereas inflammatory indices were age-invariant. Conclusions: Routine CBC ratios encode distinct \u201cinflammatory fingerprints\u201d that mirror the first metastatic destination in NSCLC: platelets herald pleural spread, neutrophils favor liver and bone, and divergent lymphocyte\u2013monocyte balances separate bone from brain. Although no substitute for cross-sectional imaging, these low-cost markers could refine clinical suspicion, guide targeted work-up, and illuminate the biology of organ-selective dissemination, particularly in resource-limited settings.<\/jats:p>","DOI":"10.3390\/medicina61091521","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T06:08:37Z","timestamp":1756102117000},"page":"1521","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Site-Specific Inflammatory Signatures in Metastatic NSCLC: Insights from Routine Blood Count Parameters"],"prefix":"10.3390","volume":"61","author":[{"given":"Vlad-Norin","family":"Vornicu","sequence":"first","affiliation":[{"name":"Doctoral School in Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"},{"name":"Department of Oncology, OncoHelp Hospital Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9838-744X","authenticated-orcid":false,"given":"Alina-Gabriela","family":"Negru","sequence":"additional","affiliation":[{"name":"Department of Cardiology, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razvan Constantin","family":"Vonica","sequence":"additional","affiliation":[{"name":"Preclinical Department, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei Alexandru","family":"Cosma","sequence":"additional","affiliation":[{"name":"Doctoral School in Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"},{"name":"Department of Oncology, OncoHelp Hospital Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania"},{"name":"Department of Microscopic Morphology\/Histology, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1628-2359","authenticated-orcid":false,"given":"Sorin","family":"Saftescu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3366-8264","authenticated-orcid":false,"given":"Mihaela Maria","family":"Pasca-Fenesan","sequence":"additional","affiliation":[{"name":"Doctoral School in Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"},{"name":"Department of Microscopic Morphology\/Histology, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9530-022X","authenticated-orcid":false,"given":"Anca Maria","family":"Cimpean","sequence":"additional","affiliation":[{"name":"Department of Microscopic Morphology\/Histology, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"},{"name":"Center of Expertise for Rare Vascular Disease in Children, Emergency Hospital for Children Louis Turcanu, 300041 Timisoara, Romania"},{"name":"Center of Genomic Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"},{"name":"Research Center for Pharmaco-Toxicological Evaluation, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"975","DOI":"10.21037\/tlcr-24-979","article-title":"Recent advancements in lung cancer research: A narrative review","volume":"14","author":"Tang","year":"2025","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Nyen, J.E., Booth, A.\u00d8., Husby, \u00d8., Bugge, C., Engebretsen, I., Oteiza, F., Helland, \u00c5., Fjellbirkeland, L., Brustugun, O.T., and Gr\u00f8nberg, B.H. (2025). Targeted treatment and survival in advanced non-squamous non-small cell lung cancer patients\u2014A nationwide and longitudinal study. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1506041"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"8794","DOI":"10.3390\/curroncol29110691","article-title":"Patterns of Extrathoracic Metastasis in Lung Cancer Patients","volume":"29","author":"Park","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Xie, T., Qiu, B.M., Luo, J., Diao, Y.-F., Hu, L.-W., Liu, X.-L., and Shen, Y. (2024). Distant metastasis patterns among lung cancer subtypes and impact of primary tumor resection on survival in metastatic lung cancer using SEER database. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-73389-6"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Cha, H.K., Lim, J.H., Ryu, W.K., Kim, L., and Ryu, J.-S. (2023). Solitary Uncommon Metastasis in Non-Small Cell Lung Cancer. Reports, 6.","DOI":"10.3390\/reports6010008"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Riaz, F., Zhang, J., and Pan, F. (2024). Forces at play: Exploring factors affecting the cancer metastasis. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1274474"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"23874","DOI":"10.18632\/oncotarget.8074","article-title":"Clinicopathologic Characteristics of EGFR, KRAS, and ALK Alterations in 6595 Lung Cancers","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"44824","DOI":"10.18632\/oncotarget.14827","article-title":"Predictive Value of Hematological Markers of Systemic Inflammation for Managing Cervical Cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1111\/1759-7714.13642","article-title":"Longitudinal analysis of complete blood count parameters in advanced-stage lung cancer patients","volume":"11","author":"Rojko","year":"2020","journal-title":"Thorac. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.3390\/curroncol31090367","article-title":"Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy","volume":"31","author":"Putzu","year":"2024","journal-title":"Curr. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3897\/pharmacia.71.e115558","article-title":"The prognostic role of markers of systemic inflammation in patients with metastatic lung cancer receiving immunotherapy: A comprehensive review of the literature","volume":"71","author":"Zlatanova","year":"2024","journal-title":"Pharmacia"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Marschollek, K., Kosacka, M., Pokryszko-Dragan, A., and Brzecka-Bonnaud, A. (2025). Complete blood count parameters as potential predictive factors of brain metastases in lung cancer. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1582788"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Lin, Y.J., Wei, K.C., Chen, P.Y., Lim, M., and Hwang, T.L. (2021). Roles of Neutrophils in Glioma and Brain Metastases. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.701383"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1097\/PAS.0b013e3181b8cf03","article-title":"Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases","volume":"33","author":"Girard","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Buonacera, A., Stancanelli, B., Colaci, M., and Malatino, L. (2022). Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073636"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12957-025-03838-7","article-title":"Prognostic value of platelet to lymphocyte ratio in patients with cervical cancer: An updated systematic review and meta-analysis","volume":"23","author":"Zhu","year":"2025","journal-title":"World J. Surg. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"31926","DOI":"10.18632\/oncotarget.7876","article-title":"Prognostic role of lymphocyte to monocyte ratio for patients with cancer: Evidence from a systematic review and meta-analysis","volume":"7","author":"Gu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13045-021-01187-y","article-title":"Neutrophils in cancer carcinogenesis and metastasis","volume":"14","author":"Xiong","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: A systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3892\/ol.2022.13588","article-title":"Role of tumor-associated neutrophils in lung cancer (Review)","volume":"24","author":"Zhou","year":"2022","journal-title":"Oncol. Lett."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13019-018-0763-0","article-title":"Neutrophil-lymphocyte ratio predicts recurrence in patients with resected stage 1 non-small cell lung cancer","volume":"13","author":"Mizuguchi","year":"2018","journal-title":"J. Cardiothorac. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.trecan.2024.01.010","article-title":"Beyond binary: Bridging neutrophil diversity to new therapeutic approaches in NSCLC","volume":"10","author":"Horvath","year":"2024","journal-title":"Trends Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejso.2007.02.014","article-title":"Elevated preoperative neutrophil-to-lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases","volume":"34","author":"Halazun","year":"2008","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e70631","DOI":"10.1002\/cam4.70631","article-title":"Elevated Neutrophil-to-Lymphocyte Ratio Correlates With Liver Metastases and Poor Immunotherapy Response in Stage IV Melanoma","volume":"14","author":"Foerster","year":"2025","journal-title":"Cancer Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Eckert, C., Klein, N., Kornek, M., and Lukacs-Kornek, V. (2015). The complex myeloid network of the liver with diverse functional capacity at steady state and in inflammation. Front. Immunol., 6.","DOI":"10.3389\/fimmu.2015.00179"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.7150\/thno.111096","article-title":"Targeting neutrophil extracellular traps in cancer progression and metastasis","volume":"15","author":"Zhang","year":"2025","journal-title":"Theranostics"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.4049\/jimmunol.1201881","article-title":"IL-6 cooperates with G-CSF to induce protumor function of neutrophils in bone marrow by enhancing STAT3 activation","volume":"190","author":"Yan","year":"2013","journal-title":"J. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/jor.1100140309","article-title":"Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysis","volume":"14","author":"Clohisy","year":"1996","journal-title":"J. Orthop. Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Maurer, S., and Ferrari de Andrade, L. (2020). NK Cell Interaction with Platelets and Myeloid Cells in the Tumor Milieu. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.608849"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Quintanilla, M., Montero-Montero, L., Renart, J., and Mart\u00edn-Villar, E. (2019). Podoplanin in Inflammation and Cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030707"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2353\/ajpath.2007.060790","article-title":"The platelet aggregation-inducing factor aggrus\/podoplanin promotes pulmonary metastasis","volume":"170","author":"Kunita","year":"2007","journal-title":"Am. J. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Tan, Y., Wang, M., Zhang, Y., Ge, S., Zhong, F., Xia, G., and Sun, C. (2021). Tumor-Associated Macrophages: A Potential Target for Cancer Therapy. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.693517"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4103\/NRR.NRR-D-23-01508","article-title":"Infiltration by monocytes of the central nervous system and its role in multiple sclerosis: Reflections on therapeutic strategies","volume":"20","author":"Zhang","year":"2025","journal-title":"Neural Regen. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1471-4159.2006.04162.x","article-title":"Macrophages are comprised of resident brain microglia not infiltrating peripheral monocytes acutely after neonatal stroke","volume":"100","author":"Denker","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_35","first-page":"3936","article-title":"Relationship between lymphocyte to monocyte ratio and brain metastasis in non-smalll cell lung cancer patients","volume":"14","author":"Liu","year":"2022","journal-title":"Am. J. Transl. Res."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Li, W.Y., Zhao, T.T., Xu, H.M., Wang, Z.-N., Xu, Y.-Y., Han, Y., Song, Y.-X., Wu, J.-H., Xu, H., and Yin, S.-C. (2019). The role of EGFR mutation as a prognostic factor in survival after diagnosis of brain metastasis in non-small cell lung cancer: A systematic review and meta-analysis. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5331-z"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.clineuro.2017.06.022","article-title":"Impacts of EGFR mutation and EGFR-TKIs on incidence of brain metastases in advanced non-squamous NSCLC","volume":"160","author":"Wang","year":"2017","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41586-019-1004-y","article-title":"Hepatocytes direct the formation of a pro-metastatic niche in the liver","volume":"567","author":"Lee","year":"2019","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.21037\/tlcr-22-638","article-title":"Targeting lung cancer brain metastases: A narrative review of emerging insights for anaplastic lymphoma kinase (ALK)-positive disease","volume":"12","author":"Nelson","year":"2023","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1158\/2159-8290.CD-14-1236","article-title":"Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities","volume":"5","author":"Skoulidis","year":"2015","journal-title":"Cancer Discov."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41571-021-00473-5","article-title":"PD-L1 as a biomarker of response to immune-checkpoint inhibitors","volume":"18","author":"Doroshow","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: Signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal. Transduct. Target Ther."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Nishida, A., and Andoh, A. (2025). The Role of Inflammation in Cancer: Mechanisms of Tumor Initiation, Progression, and Metastasis. Cells, 14.","DOI":"10.3390\/cells14070488"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/9\/1521\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:35:27Z","timestamp":1760034927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/9\/1521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["medicina61091521"],"URL":"https:\/\/doi.org\/10.3390\/medicina61091521","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]}}}